Saint Marys Hospital Inc
Analysis
Saint Marys Hospital Inc is a registered charity in United States, based in Hartford, CT. It received its IRS tax-exemption ruling in October 1977, 49 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a hospital or medical research organisation under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending September 2023, Saint Marys Hospital Inc reported income of $330.2m and spending of $325.2m, spending 99% of its income. Across the 5 years on record, from September 2019 to September 2023, income fell from $333.3m to $330.2m (-0.9%), an average of -0.2% a year. Over the whole period it spent 93% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Saint Marys Hospital Inc sits at the 98th percentile: it is larger than about 98% of them. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 100th percentile within CT. Charities of a similar size with the same main cause include City of Hope ($330.0m), Wellstar North Fulton Hospital Inc ($330.4m) and The American Oncologic Hospital ($329.4m).
On its Form 990 for the period ending September 2023, revenue came from contributions and grants 0.6% and program service revenue 99% of the total. Compensation of current officers, directors and key employees was $825k (0.3% of expenses). Other salaries and wages came to $85.7m. At year end it held assets of $270.3m against liabilities of $90.4m, net assets of $179.9m.
Income and spending
Where the income comes from
- Contributions & grants 0.6%
- Program services 99%
- Other 0.4%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| City of Hope | Duarte | $330.0m |
| Wellstar North Fulton Hospital Inc | Marietta | $330.4m |
| The American Oncologic Hospital | Philadelphia | $329.4m |
| Marshall Medical Center | Placerville | $331.0m |